• G10635

RES
1b:b-dglc-HEX-1:5
2s:n-acetyl
3b:b-dgal-HEX-1:5
4b:a-lgal-HEX-1:5|6:d
LIN
1:1d(2+1)2n
2:1o(4+1)3d
3:3o(2+1)4d

• Appelmelk BJ et al. Phase variation in H type I and Lewis a epitopes of Helicobacter pylori lipopolysaccharide. Infect Immun. 2000 Oct;68:(10):5928-32. doi: 10.1128/iai.68.10.5928-5932.2000. PMID: 10992504.

• Kitamura K et al. Specificity analysis of blood group Lewis-y (Le(y)) antibodies generatedagainst synthetic and natural Le(y) determinants. Proc Natl Acad Sci U S A. 1994 Dec 20;91:(26):12957-61. doi: 10.1073/pnas.91.26.12957. PMID: 7809154.

• Holmes EH et al. Synthesis of type 1 and 2 lacto series glycolipid antigens in human colonic adenocarcinoma and derived cell lines is due to activation of a normally unexpressed beta 1----3N-acetylglucosaminyltransferase. J Biol Chem. 1987 Nov 15;262:(32):15649-58. PMID: 2960671.

• Nakajima T et al. Immunochemical characterization of anti-H monoclonal antibodies obtained from a mouse immunized with human saliva. J Immunol Methods. 1993 Feb 26;159:(1-2):261-7. doi: 10.1016/0022-1759(93)90165-4. PMID: 8445257.

• Imai K et al. Circulating blood group-related antigen(s) in cancer patients detected by the monoclonal antibodies produced against hepatocellular carcinoma cell line. Tumour Biol. 1985;6:(3):257-72. PMID: 2416034.

• Yazawa S et al. Development and characterization of a novel anti-fucosylated antigen monoclonal antibody YB-2 and its usefulness in the immunohistochemical diagnosis of colorectal cancer. Jpn J Cancer Res. 1993 Jun;84:(6):641-8. doi: 10.1111/j.1349-7006.1993.tb02024.x. PMID: 8340252.

• Chapman CM et al. Use of monoclonal antibodies for the localization of tissue isoantigens A and B in transitional cell carcinoma of the upper urinary tract. J Histochem Cytochem. 1983 Apr;31:(4):557-61. doi: 10.1177/31.4.6827085. PMID: 6827085.

• Yazawa S et al. Tumor-related expression of alpha1,2fucosylated antigens on colorectal carcinoma cells and its suppression by cell-mediated priming using sugar acceptors for alpha1,2fucosyltransferase. Glycobiology. 2002 Sep;12:(9):545-53. doi: 10.1093/glycob/cwf070. PMID: 12213787.

• Young WW Jr et al. Two monoclonal anticarbohydrate antibodies directed to glycosphingolipids with a lacto-N-glycosyl type II chain. J Biol Chem. 1981 Nov 10;256:(21):10967-72. PMID: 7287743.

• Nakamura J et al. The usefulness of anti-fucosylated antigen antibody YB-2 for diagnosis of hepatocellular carcinoma. Glycoconj J. 1997 Jan;14:(1):81-7. doi: 10.1023/a:1018517116368. PMID: 9076517.

• Clausen H et al. Repetitive A epitope (type 3 chain A) defined by blood group A1-specific monoclonal antibody TH-1: chemical basis of qualitative A1 and A2 distinction. Proc Natl Acad Sci U S A. 1985 Feb;82:(4):1199-203. doi: 10.1073/pnas.82.4.1199. PMID: 2579390.

• McGaughy J et al. Behavioral vigilance following infusions of 192 IgG-saporin into the basal forebrain: selectivity of the behavioral impairment and relation to cortical AChE-positive fiber density. Behav Neurosci. 1996 Apr;110:(2):247-65. doi: 10.1037//0735-7044.110.2.247. PMID: 8731052.

• Fredman P et al. A monoclonal antibody that precipitates the glycoprotein receptor for epidermal growth factor is directed against the human blood group H type 1 antigen. J Biol Chem. 1983 Sep 25;258:(18):11206-10. PMID: 6309836.

• Naitoh H et al. The recognition of cancer-associated fucosylated antigens in colorectal cancer by a novel monoclonal antibody, YB-2. Surg Today. 1994;24:(4):382-4. doi: 10.1007/BF02348574. PMID: 8038519.